Presentation TCT 2016 How Would I Treat? (Option 2) Presenter: Runlin Gao, Bo Xu, Zening Jin November 01, 2016
Presentation TCT 2016 How Would I Treat? (Option 1) Presenter: Runlin Gao, Bo Xu, Philippe Généreux November 01, 2016
Presentation TCT 2016 Case Introduction: How Should I Treat? Presenter: Runlin Gao, Bo Xu, Kefei Dou November 01, 2016
News Conference News TCT 2016 Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence Todd Neale November 01, 2016
News Conference News TCT 2016 TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function Todd Neale November 01, 2016
News Industry News Five Year Echocardiogram Follow-Up Data Demonstrates Sustained Durability After Transcatheter Aortic Valve Replacement In High-Risk And Inoperable Patients November 01, 2016
Presentation TCT 2016 PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis Presenter: Gregg W. Stone, Philippe Pibarot, Pamela S. Douglas November 01, 2016
News Industry News TCT 2016 Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement November 01, 2016
Presentation TCT 2016 PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen November 01, 2016
Presentation TCT 2016 Case #3: A Novel Issue With a Bioresorbable Scaffold Presenter: Antonio Colombo, Jeffrey W. Moses, Carlo Di Mario October 31, 2016
Presentation TCT 2016 Case 3: Presenter: Parag Barwad, Raju Narasa Kavalipati, Narenda N. Khanna, Fazila T. Malik, Manotosh Panja, Gokul M. Reddy, Kamal K. Sethi, Rabin dra Nath Chakraborty October 31, 2016
Presentation TCT 2016 Case 3: Heavily Calcified Vessel Presenter: Jun-Jack Cheng, Gary S. Mintz, Chiung Jen Wu, Wen-Lieng Lee October 31, 2016
Presentation TCT 2016 PARTNER 2 and SAPIEN 3 Critique: Pros and Cons Presenter: William A. Gray, Stephan Windecker October 31, 2016
Presentation TCT 2016 Trial #6 - The Essentials of PARTNER 2 and SAPIEN 3 - TAVR In Intermediate Risk Patients, and Improved TAVR Devices Presenter: William A. Gray, Stephan Windecker, Vinod H. Thourani October 31, 2016
Presentation TCT 2016 TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial Presenter: Charles J. Davidson, Michael J. Reardon, Philip Green October 31, 2016
Presentation TCT 2016 TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial Presenter: Charles J. Davidson, Michael J. Reardon, Suzanne Baron October 31, 2016
Presentation TCT 2016 Case #3: CTO PCI: Keep It Simple Presenter: Afzalur Rahman, Kaisar Nasrullah Khan October 30, 2016
Presentation TCT 2016 Low-Risk Studies: Design and Updates II - The PARTNER 3 Low-Risk Trial Presenter: Patrick T. O'Gara, Alec S. Vahanian, Michael J. Mack October 30, 2016
Presentation TCT 2016 Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials Presenter: Patrick T. O'Gara, Alec S. Vahanian, Susheel K. Kodali October 30, 2016
News Industry News Corindus Vascular Robotics Receives FDA Clearance for Next Generation Robotic System October 27, 2016